Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Erwin Mangubat

Neurological Surgery Columbia, SC Medical Doctor

NPI 1285890046 CMS profile 1141048

3 Richland Medical Park Dr, Suite 310, Columbia, SC 29203

Open in the dashboard

General payments

$28,690

307 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Erwin Mangubat of Columbia, SC is reported in the CMS Open Payments database as having received $28,690 across 307 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,257 86
2024 General $2,624 48
2023 General $1,535 40
2022 General $5,938 48
2021 General $3,387 46
2020 General $397 10
2019 General $1,552 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erwin Mangubat
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Erwin Mangubat were reported at $13,257. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Erwin Mangubat Neurological Surgery median Middle half National median
2019 $1,552 $582 $138–$3,006 $163
2020 $397 $294 $76–$2,174 $114
2021 $3,387 $387 $105–$2,432 $132
2022 $5,938 $542 $139–$2,989 $149
2023 $1,535 $534 $145–$2,697 $160
2024 $2,624 $574 $155–$3,046 $164
2025 $13,257 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $7,677 17 payments
  2. Medtronic, Inc. $6,101 107 payments
  3. Stryker Corporation $2,622 44 payments
  4. Globus Medical, Inc. $1,892 2 payments
  5. Alphatec Spine, Inc $1,787 5 payments
  6. Imperative Care, INc $1,450 22 payments
  7. Kyocera Medical Technologies, Inc. $1,277 2 payments
  8. Medtronic USA, Inc. $1,249 16 payments
  9. DePuy Synthes Sales Inc. $976 36 payments
  10. Spineology Inc. $967 2 payments
  11. Other $2,691 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,718 267 payments
  2. Travel and Lodging $11,224 30 payments
  3. Consulting Fee $5,700 2 payments
  4. Education $31 7 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17 1 payment
Products named General payments · program years 2019–2025
  1. Spotlight $6,000 2 payments
  2. Spine $1,828 1 payment
  3. EVEREST SPINAL SYSTEM $1,674 10 payments
  4. CEREPAK UNIFORM $1,673 19 payments
  5. Other - Miscellaneous $1,590 2 payments
  6. MAZOR X SYSTEM $1,268 22 payments
  7. ZOOM 88-T LARGE DISTAL PLATFORM $1,161 14 payments
  8. Mazor X Stealth Edition $1,140 10 payments
  9. ACTIVA $1,122 10 payments
  10. OptiMesh Interbody Fusion System $967 2 payments
  11. Other $7,118 205 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 98 billing codes

Paid by Medicare

$204,969

Medicare's payments for the services billed

Medicare patients

263

Average age 73

Services billed

762

152 women, 111 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Depression 39%
Diabetes 34%
Ischemic heart disease 32%
Chronic kidney disease 28%
Heart failure 22%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

307 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record